跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Clindamycin-hameln Solution for Injection 150mg/ml - HSA Drug Approval Details
Approvals
/
HSA
/
Clindamycin-hameln Solution for Injection 150mg/ml
Approved
THERAPEUTIC
Clindamycin-hameln Solution for Injection 150mg/ml
Siegfried Hameln GmbH (GERMANY)
🇸🇬 Health Sciences Authority
Approval Date
Sep 3, 2014
Approval ID
9e917d2f13ecd99a
Company
Siegfried Hameln GmbH (GERMANY)
Type
Therapeutic
Approval Details
Approval Id
9e917d2f13ecd99a
Drug Name
Clindamycin-hameln Solution for Injection 150mg/ml
Product Name
Clindamycin-hameln Solution for Injection 150mg/ml
Approval Number
SIN14599P
Approval Date
2014-09-03
Registrant
ZYFAS PHARMA PTE LTD
Licence Holder
ZYFAS PHARMA PTE LTD
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
INJECTION, SOLUTION
Route Of Administration
INTRAVENOUS, INTRAMUSCULAR
Atc Code
J01FF01
Atc Item Name
clindamycin
Pharma Manufacturer Name
ZYFAS PHARMA PTE. LTD.
Company Detail Path
/organization/zyfas-pharma-pte-ltd
Active Ingredients
Clindamycin Phosphate 178.23 mg/ml eqv Clindamycin
150 mg/ml
CLINDAMYCIN PHOSPHATE 178.23 MG/ML EQV CLINDAMYCIN
150 MG/ML
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Sep 3, 2014
Approval ID
9e917d2f13ecd99a
Type
Therapeutic
Back to HSA Approvals
